Tokyo, May 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061689) titled 'A Retrospective Analysis of ADC Target Antigen Expression Profiles and Their Prognostic Significance in Endometrial Cancer' on May 26.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Endometrial cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to comprehensively analyze the expression of ADC target antigens, including HER2, TROP2, B7-H4, FRalpha, CDH6, HER3, and B7-H3, and their associations with hormone receptor status, including estrogen receptor and progesterone recepto...